A2058 and A375 cells express intermediate levels of GALC mRNA and protein when compared to other human melanoma cell lines (Supplementary Figure S1), being therefore suitable for assessing the impact of the upregulation of this enzyme on the biological behavior of human melanoma cells in a BRAF-mutated background. The gene discussed is BRAF; the disease is melanoma.